Jamjoom Pharmaceuticals Factory Company

TADAWUL-4015
Saudi Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#5634
Country Rank
#50
Market Cap
2.9 B
Price
41.44
Change (%)
0.06%
Volume
23,982

Jamjoom Pharmaceuticals Factory Company's latest marketcap:

2.9 B

As of 04/30/2026, Jamjoom Pharmaceuticals Factory Company's market capitalization has reached $2.9 B. According to our data, Jamjoom Pharmaceuticals Factory Company is the 5634th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.9 B
Revenue (ttm) 400.12 M
Net Income (ttm) 123.67 M
Shares Out 70 M
EPS (ttm) 1.77
Forward PE 0.00
Ex-Dividend Date 03/02/2026
Earnings Date 04/30/2026
Market Cap Chart
Data Updated: 04/30/2026

Jamjoom Pharmaceuticals Factory Company's yearly market capitalization.

Jamjoom Pharmaceuticals Factory Company has seen its market value grow from 8.05 B SAR to 10.93 B SAR since 2023, representing a total increase of 35.74% and an annual compound growth rate (CAGR) of 13.47%.
Date Market Cap Market Cap(USD) Change (%) Global Rank
06/01/2026 10.93 B $2.91 B 9.7% n/a
12/31/2025 9.96 B $2.65 B -6.5% 4451
12/31/2024 10.65 B $2.83 B 32.35% 4535
12/31/2023 8.05 B $2.14 B 5377

Company Profile

About Jamjoom Pharmaceuticals Factory Company

Jamjoom Pharmaceuticals Factory Company is a leading manufacturer and marketer of pharmaceutical products, operating both in the Kingdom of Saudi Arabia and internationally.

Product Portfolio

The company specializes in a diverse range of pharmaceutical and healthcare products, including:

  • Human medicines and nutraceuticals
  • Antibiotics and general analgesics
  • Medicines for respiratory conditions (cough, allergy, asthma)
  • Cardiovascular treatments (heart diseases, blood pressure)
  • Gastrointestinal solutions (diarrhea, vomiting, ulcer, acidity)
  • Dermatological products for skin infections
  • Oncology medicines for cancer diseases
  • Ophthalmic care (eye drops and ointments)
  • Cosmeceuticals

Company Background

Founded in 1994, Jamjoom Pharmaceuticals is headquartered in Jeddah, Saudi Arabia, and has established itself as a trusted name in the pharmaceutical industry.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.